Bacteriophages have many uses in fields such as human medicine, veterinary medicine, aquaculture, agriculture, and food production. Bacteriophages can become an effective, natural, and environmentally friendly tool against antibiotic resistance in humans and animals. The United Nations defines antibiotic resistance as one of the world's greatest public health challenges. At the same time, animal health, food safety, the environment, and the economy are all threatened worldwide. It means that modern medicine faces the danger of being unable to perform, and the risk of complications and prolonged hospital stays increases. It is also a threat to welfare and the world economy. The widespread use of antibiotics makes many important sectors face the challenge of antibiotic resistance. In a world where everyone affects everyone, the problem of antibiotic resistance must be solved from the perspective of cross-sectoral and cross-border "one health". The global consumption of antibiotics must be reduced, and new treatments for harmful bacteria must be developed.
Creative Biolabs is one of the companies based on phage drug discovery. Creative Biolabs' phage project is to develop phage-based solutions and provide drug discovery services to challenge bacteria in the medical, animal health, and aquaculture industries. We can provide these solutions listed as follows:
Identify the targets that bacterial viruses or phages use to prevent bacterial growth, and then screen small molecule inhibitors that attack the same targets against these targets, providing a unique platform for the discovery of new antibiotics.
Our global in vitro analysis and screening scientists have expertise in various therapeutic fields, target types, analysis formats, instruments, and automation platforms, and they are committed to helping you identify and develop the most promising biology and chemistry.
Our in vitro safety pharmacology service portfolio includes thousands of tests, including combined and functional tests for all major target categories. All in vitro safety pharmacology tests are designed and implemented by our experienced global team of technical experts.
We provide a comprehensive range of non-clinical ADME PK and toxicological analyses to evaluate drug metabolism and safety characteristics early in the drug discovery process.
Phage display is one of our important drug discovery platforms, in large part because it can recognize a wide range of biological agents, including peptides, antibodies, and other proteins, and can design many properties of successful drugs, such as potency and specificity, cross-reactivity and stability.
Creative Biolabs can meet the needs of customers by providing drug discovery solutions on time and on budget. We have in-depth knowledge and experience of the tools and processes involved in the phage projects. Our skilled and dedicated scientific researchers ensure that the most suitable methods and techniques are selected for your project. If necessary, please feel free to contact us.
Please kindly note that our services can only be used to support research purposes (Not for clinical use).
Creative Biolabs is a globally recognized phage company. Creative Biolabs is committed to providing researchers with the most reliable service and the most competitive price.
